Skip to content
Senolytics Discovery Human Trials Prof Paul Robbins Ep 3 episode artwork

Jun 15, 2022 8 min

Senolytics Discovery Human Trials Prof Paul Robbins Ep 3

from Modern Healthspan Hosted by Modern Healthspan

In this video Professor Robbins discusses the process by which his and other labs look for possible senolytics. He also talks about fisetin and why he chooses to take it Dr. Robbins is a Professor of Biochemistry, Molecular Biology and Biophysics and Associate Director of the Institute on the Biology of Aging and Metabolism (iBAM) at the University of Minnesota. He was part of a collaborative team that was the first to identify senotherapeutic compounds, able to reduce the senescent cell burden and extend healthspan and lifespan in mouse models that are now in more than 15 clinical trials. Professor Robbins' page at University of Minnesota https://robbins.umn.edu/dr-paul-robbins-phd Institute of the Biology of Aging and Metabolism If you would like to support our channel, we’d love a coffee ☕…thank you! https://www.buymeacoffee.com/mhealthspan You can also find us on YouTube at https://www.youtube.com/c/modernhealthspan

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Senolytics Discovery Human Trials Prof Paul Robbins Ep 3

0:00 8:08

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Modern Healthspan?

This episode is 8 minutes long.

When was this Modern Healthspan episode published?

This episode was published on June 15, 2022.

Can I download this Modern Healthspan episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.